COMMITMENTS AND CONTINGENCIES (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2021
USD ($)
$ / shares
shares
| |
| Commitments and Contingencies [Line items] | |
| Deferred Fee Per Unit | $ 0.35 |
| Deferred underwriting fee payable | $ | $ 12,075,000 |
| Common shares, par value (in dollars per share) | $ 0.0001 |
| PIPE Investment | Subscription Agreements | |
| Commitments and Contingencies [Line items] | |
| Number of shares issued | shares | 5,080,409 |
| Purchase price | $ 10.00 |
| Aggregate gross proceeds | $ | $ 50,800,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Represents the deferred fee per unit. No definition available.
|
| X | ||||||||||
- Definition The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|